SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cytori Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: SnowShredder who wrote (151)10/5/2007 2:05:25 PM
From: kaaskopp  Read Replies (1) | Respond to of 251
 
Hi Snow,

It really doesnt make sense for Cellerix to make a deal with Cytori since the technology is totally different.

Celution has been developed to produce a therapeutic dose of fresh cells from adipose tissue within one hour.

Cellerix fractions/selects certain cells from adipose tissue- culture them for 4-6 weeks, before putting them back into the patient.

They are clearly competitors- and will surely remain so.